These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23795867)

  • 1. Sustained release of matrix metalloproteinase-3 to trabecular meshwork cells using biodegradable PLGA microparticles.
    Turturro S; Sunoqrot S; Ying H; Hong S; Yue BYJT
    Mol Pharm; 2013 Aug; 10(8):3023-3032. PubMed ID: 23795867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits.
    Fu J; Sun F; Liu W; Liu Y; Gedam M; Hu Q; Fridley C; Quigley HA; Hanes J; Pitha I
    Mol Pharm; 2016 Sep; 13(9):2987-95. PubMed ID: 27336794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of physostigmine-loaded polymeric microparticles for pretreatment against exposure to organophosphate agents.
    Chaw CS; Tan CW; Yang YY; Wang L; Moochhala S
    Biomaterials; 2003 Mar; 24(7):1271-7. PubMed ID: 12527268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release behaviour of protein-loaded microparticles prepared via coaxial or emulsion electrospray.
    Wang Y; Yang X; Liu W; Zhang F; Cai Q; Deng X
    J Microencapsul; 2013; 30(5):490-7. PubMed ID: 23346923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
    Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
    Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites.
    Ruhe PQ; Hedberg EL; Padron NT; Spauwen PH; Jansen JA; Mikos AG
    J Bone Joint Surg Am; 2003; 85-A Suppl 3():75-81. PubMed ID: 12925613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of PLGA microparticle properties loaded with micronized, nanosized or dissolved drug.
    Zhang C; Bodmeier R
    Int J Pharm; 2022 Nov; 628():122313. PubMed ID: 36272513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of a heterogeneous human placental matrix from PLGA microparticles to modulate angiogenesis.
    Tonello S; Moore MC; Sharma B; Dobson J; McFetridge PS
    Drug Deliv Transl Res; 2016 Apr; 6(2):174-83. PubMed ID: 26864696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
    Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
    Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
    Sweet JL; Pillay V; Choonara YE
    Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.
    Lin Y; Li Y; Ooi CP
    J Mater Sci Mater Med; 2012 Oct; 23(10):2453-60. PubMed ID: 22843166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).
    Gupta V; Davis M; Hope-Weeks LJ; Ahsan F
    Pharm Res; 2011 Jul; 28(7):1733-49. PubMed ID: 21626061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.
    Hu Y; Hollinger JO; Marra KG
    J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
    Oh JE; Nam YS; Lee KH; Park TG
    J Control Release; 1999 Feb; 57(3):269-80. PubMed ID: 9895414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods.
    Zhang XQ; Intra J; Salem AK
    J Microencapsul; 2008 Feb; 25(1):1-12. PubMed ID: 18188727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery.
    Intra J; Salem AK
    J Pharm Sci; 2010 Jan; 99(1):368-84. PubMed ID: 19670295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.